EDUCATIONAL OBJECTIVES
After attending this activity, the participant will demonstrate the ability to:
  • Apply new information on the pathogenesis of HIV and liver disease due to viral hepatitis and metabolic-associated fatty liver disease (MAFLD) in management strategies
  • Identify antiretroviral and HBV/HCV/HDV antiviral therapies based upon the most recent USPHS, IAS-USA, AASLD, IDSA and EASL Guidelines.
  • Evaluate patients with antiretroviral and/or DAA therapy failure based upon the most recent data presented at the previous EASL, CROI, AASLD, HIV Glasgow, IAC, ICAAC, IDWeek, and EACS conferences.
  • Manage antiviral (HIV, HBV, HCV, HDV and MAFLD/NASH) drug interactions, side effects, and complications of treatment incorporating the latest pharmacogenomics/kinetics/dynamics data
  • Evaluate and manage patients for pre-exposure prophylaxis therapy to prevent HIV infection
  • Identify management strategies of sexually transmitted infections in patients with HIV or liver disease due to viral hepatitis and metabolic-associated fatty liver disease (MAFLD)
  • Identify new prevention and management strategies for emerging pathogens such as COVID and monkeypox


AGENDA

 

Saturday, March 18, 2023

 

07:00 AM – 08:00 AM Breakfast  

 

08:00 AM – 08:10 AM Introduction and Conference Goals Michael S. Saag, MD

 

08:10 AM – 08:35 AM Antiretroviral Therapy: Starts, Switches and Rescues – Where Are We Now? Joseph J. Eron Jr., MD

 

08:35 AM – 09:00 AM New Drugs for HIV Roy M. Gulick, MD, MPH

 

09:00 AM – 09:25 AM Panel Discussion / Questions and Answers  

 

09:25 AM – 09:50 AM Post-Conference Update from CROI 2023 Rajesh T. Gandhi, MD

 

09:50 AM – 10:15 AM Hot Topics in Pharmacology: How to Deliver RNA Charles W. Flexner, MD

 

10:15 AM – 10:40 AM Panel Discussion / Questions and Answers  

 

10:40 AM – 10:55 AM Break  

 

10:55 AM – 11:20 AM Sexually Transmitted Infections: The Old & New Christina Muzny, MD

 

11:20 AM – 11:45 AM Pre-exposure Prophylaxis for HIV Infection Raphael Landovitz, MD, MSc

 

11:45 AM – 12:10 PM Panel Discussion / Questions and Answers  

 

12:10 PM – 12:35 PM Break  

 

12:35 PM – 01:25 PM Working Lunch - Case Presentations   Michael S. Saag, MD and faculty panel

 

01:30 PM – 02:00 PM Faculty Roundtable Session 1*  

 

02:00 PM – 02:30 PM Faculty Roundtable Session 2*
(In-person attendees will have the opportunity to attend two of the four sessions)
PrEP, Prevention and STI’s Rafael Landovitz, MD, MSc
Christina Muzny, MD
Antiretroviral Therapy: Challenging Cases Joseph J. Eron, Jr., MD
Glenn J. Treisman, MD, PhD
Emerging Advances in HIV Treatment Charles W. Flexner, MD
Roy M. Gulick, MD, MPH
Emerging Pathogens: COVID / Monkey Pox Rajesh T. Gandhi, MD
Michael S. Saag, MD

 

Sunday, March 19, 2023

 

07:00 AM – 08:00 AM Breakfast  

 

08:00 AM – 08:10 AM Introduction and Conference Goals Mark S. Sulkowski, MD

 

08:10 AM – 08:35 AM Management Considerations for Hepatitis C Susanna Naggie, MD, MHS

 

08:35 AM – 09:00 AM Management Considerations for Hepatitis B Monoinfection Jordan Feld, MD, MPH

 

09:00 AM – 09:25 AM Panel Discussion / Questions and Answers  

 

09:25 AM – 09:50 AM Management Considerations for Hepatitis B Coinfected Debika Bhattacharya MD, MSc

 

09:50 AM – 10:15 AM Hepatitis D virus: A re-emerging pathogen with new treatment options Kenneth E. Sherman, MD

 

10:15 AM – 10:40 AM Panel Discussion / Questions and Answers  

 

10:40 AM – 10:55 AM Break  

 

10:55 AM – 11:20 AM HIV, Obesity, and Metabolic Associated Fatty Liver Disease Jordan Lake, MD, MSc

 

11:20 AM – 11:45 AM Approaches to Managing the Mental Health of Healthcare Providers Glenn J. Treisman, MD, PhD

 

11:45 AM – 12:10 PM Panel Discussion / Questions and Answers  

 

12:10 PM – 12:35 PM Break  

 

12:35 PM – 01:25 PM Working Lunch - Case Presentations Mark S. Sulkowski, MD and faculty panel

 

01:30 PM – 02:00 PM Faculty Roundtable Session 1*  

 

02:00 PM – 02:30 PM Faculty Roundtable Session 2*
(In-person attendees will have the opportunity to attend two of the four sessions)
Hepatitis C: Challenging Cases Susanna Naggie, MD, MHS
Mark Sulkowski, MD
Hepatitis B and D: More Questions and Answers Debika Bhattacharya MD, MSc
Jordan Feld, MD, MPH
Fatty Liver Disease Jordan Lake, MD, MSc
Kenneth E. Sherman, MD
Substance Abuse Disorder Michael S. Saag, MD
Glenn J. Treisman, MD, PhD

 

* Faculty Roundtable sessions are only available for in-person conference participants. These sessions will not be available for virtual participants.

The schedule of events and faculty are subject to change.



Rush Logo

This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications.

Practice Point Communications and Rush University Medical Center do not share your name or contact information with any other party.